69 related articles for article (PubMed ID: 7517664)
1. Binding and bioeffects of Ipriflavone on a human preosteoclastic cell line.
Benvenuti S; Petilli M; Frediani U; Tanini A; Fiorelli G; Bianchi S; Bernabei PA; Albanese C; Brandi ML
Biochem Biophys Res Commun; 1994 Jun; 201(3):1084-9. PubMed ID: 7517664
[TBL] [Abstract][Full Text] [Related]
2. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line.
Benvenuti S; Tanini A; Frediani U; Bianchi S; Masi L; Casano R; Bufalino L; Serio M; Brandi ML
J Bone Miner Res; 1991 Sep; 6(9):987-96. PubMed ID: 1665005
[TBL] [Abstract][Full Text] [Related]
3. Cytological and ultrastructural investigation on osteoblastic and preosteoclastic cells grown in vitro in the presence of ipriflavone: preliminary results.
Bonucci E; Silvestrini G; Ballanti P; Masi L; Franchi A; Bufalino L; Brandi ML
Bone Miner; 1992 Oct; 19 Suppl 1():S15-25. PubMed ID: 1422316
[TBL] [Abstract][Full Text] [Related]
4. Bioeffects of a nitric oxide donor in a human preosteoclastic cell line.
Mancini L; Becherini L; Benvenuti S; Brandi ML
Int J Clin Pharmacol Res; 1997; 17(2-3):93-6. PubMed ID: 9403362
[TBL] [Abstract][Full Text] [Related]
5. Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function.
Miyauchi A; Notoya K; Taketomi S; Takagi Y; Fujii Y; Jinnai K; Takahashi K; Chihara K; Fujita T
Endocrinology; 1996 Aug; 137(8):3544-50. PubMed ID: 8754785
[TBL] [Abstract][Full Text] [Related]
6. In vitro structural and functional relationships between preosteoclastic and bone endothelial cells: a juxtacrine model for migration and adhesion of osteoclast precursors.
Formigli L; Orlandini SZ; Benvenuti S; Masi L; Pinto A; Gattei V; Bernabei PA; Robey PG; Collin-Osdoby P; Brandi ML
J Cell Physiol; 1995 Feb; 162(2):199-212. PubMed ID: 7529767
[TBL] [Abstract][Full Text] [Related]
7. Evidence for bioeffects of LY 139478 on the human pre-osteoclastic cell line FLG 29.1.
Fiorelli G; Gori F; Frediani U; Morelli AM; Falchetti A; Benvenuti S; Masi L; Brandi ML
Biochem Biophys Res Commun; 1995 Jun; 211(3):857-63. PubMed ID: 7598715
[TBL] [Abstract][Full Text] [Related]
8. Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor.
Gattei V; Aldinucci D; Quinn JM; Degan M; Cozzi M; Perin V; Iuliis AD; Juzbasic S; Improta S; Athanasou NA; Ashman LK; Pinto A
Cell Growth Differ; 1996 Jun; 7(6):753-63. PubMed ID: 8780889
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of binding sites and bioeffects of raloxifene on the human leukemic cell line FLG 29.1.
Fiorelli G; Martineti V; Gori F; Benvenuti S; Frediani U; Formigli L; Zecchi S; Brandi ML
Biochem Biophys Res Commun; 1997 Nov; 240(3):573-9. PubMed ID: 9398606
[TBL] [Abstract][Full Text] [Related]
10. Ipriflavone inhibits murine osteoclast formation in vitro.
Morita I; Sakaguchi K; Kurachi T; Murota S
Calcif Tissue Int; 1992; 51 Suppl 1():S7-10. PubMed ID: 1422984
[TBL] [Abstract][Full Text] [Related]
11. Interactions between ipriflavone and the estrogen receptor.
Petilli M; Fiorelli G; Benvenuti S; Frediani U; Gori F; Brandi ML
Calcif Tissue Int; 1995 Feb; 56(2):160-5. PubMed ID: 7736326
[TBL] [Abstract][Full Text] [Related]
12. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
14. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
15. 17beta-estradiol induces apoptosis in the preosteoclastic FLG 29.1 cell line.
Zecchi-Orlandini S; Formigli L; Tani A; Benvenuti S; Fiorelli G; Papucci L; Capaccioli S; Orlandini GE; Brandi ML
Biochem Biophys Res Commun; 1999 Feb; 255(3):680-5. PubMed ID: 10049770
[TBL] [Abstract][Full Text] [Related]
16. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
Lark MW; Stroup GB; Hwang SM; James IE; Rieman DJ; Drake FH; Bradbeer JN; Mathur A; Erhard KF; Newlander KA; Ross ST; Salyers KL; Smith BR; Miller WH; Huffman WF; Gowen M
J Pharmacol Exp Ther; 1999 Nov; 291(2):612-7. PubMed ID: 10525079
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
18. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of osteoclastogenesis and osteoclast function by apigenin.
Bandyopadhyay S; Lion JM; Mentaverri R; Ricupero DA; Kamel S; Romero JR; Chattopadhyay N
Biochem Pharmacol; 2006 Jul; 72(2):184-97. PubMed ID: 16750176
[TBL] [Abstract][Full Text] [Related]
20. Ipriflavone metabolite-III inhibits LPS-induced nitric oxide release from RAW-264.7 cells.
Koncz S; Horváth EJ
Acta Physiol Hung; 1996; 84(3):223-8. PubMed ID: 9219593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
